SOURCE: InspireMD, Inc.

InspireMD, Inc.

October 08, 2015 08:00 ET

InspireMD to Present at Dawson James Securities Growth Stock Conference

BOSTON, MA--(Marketwired - Oct 8, 2015) - InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, announced today that Chief Executive Officer, Alan Milinazzo, will present at the Dawson James Securities Growth Stock Conference on October 15, 2015. The presentation will take place at 9:00 A.M. ET in the Wyndham Grand Hotel in Jupiter, Florida.

About InspireMD, Inc.

InspireMD (www.inspiremd.com) seeks to utilize its proprietary MGuard™ with MicroNetTM technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events.

InspireMD intends to pursue applications of this MicroNet technology in coronary, carotid (CGuardTM), neurovascular, and peripheral artery procedures. InspireMD's common stock is quoted on the NYSE MKT under the ticker symbol NSPR.

About Dawson James Securities

Dawson James Securities, Inc., a member of FINRA/SIPC, is a full service investment bank headquartered in Boca Raton, FL. http://www.dawsonjames.com.

Contact Information

  • Investor Contacts:

    InspireMD, Inc.
    Craig Shore
    Chief Financial Officer
    Phone: 1-888-776-6804
    Email: craigs@inspiremd.com

    PCG Advisory
    Vivian Cervantes
    Investor Relations
    Phone: (212) 554-5482